and European Union for the treatment of C

The European Union awarded $7.6 million to a research consortium comprised of 4SC AG, of Planegg-Martinsried, Germany, Anaxomics Biotech, of Spain, and a number of European Universities for the purpose of investigating the link between periodontal disease and rheumatoid arthritis (RA

The European Union awarded $7.6 million to a research consortium comprised of 4SC AG, of Planegg-Martinsried, Germany, Anaxomics Biotech, of Spain, and a number of European Universities for the purpose of investigating the link between periodontal disease and rheumatoid arthritis (RA

That led to a significant 70 percent reduction in scar size vs...Clavis expects to complete recruitment for the Phase III trial by the end of 2011 and to report top-line results in the second half of 2012

Trophos SA, of Marseille, France, said that it received a European Union award of €6 million (US$8 million) to support MitoCare, a two-and-a-half year international, translational medicine project that will begin in January 2011 and will be conducted by a 16-partner consortium led by Trophos

Trophos SA, of Marseilles, France, said that data presented by the company and partners in the European Union-funded MitoTarget consortium in four posters at the Society for Neuroscience (SfN) Meeting this week in San Diego demonstrated the potential for treating a range of neurodegenerative diseases including Alzheimer's and Huntington's by targeting mitochondrial dysfunction and also focused on mechanisms involved in neuronal metabolism and death

If the MAA is approved, the company expects Pixuvri to receive marketing authorization in European Union member states...Trophos SA, of Marseilles, France, said that data presented by the company and partners in the European Union-funded MitoTarget consortium in four posters at the Society for Neuroscience (SfN) Meeting this week in San Diego demonstrated the potential for treating a range of neurodegenerative diseases including Alzheimer's and Huntington's by targeting mitochondrial dysfunction

This positive opinion clears the way for CTI to submit its marketing authorization application in the European Union later this quarter in relapsed or refractory aggressive non-Hodgkin's lymphoma

AstraZeneca plc, of London, and Pozen Inc., of Chapel Hill, N.C., said that Vimovo (naproxen/ esomeprazole magnesium) 500/20 mg modified-release tablets cleared an important regulatory milestone by receiving positive agreement for approval in 23 countries across the European Union

Sequella Inc., of Rockville, Md., signed an agreement with the Ludwig-Maximilians-University, of Munich, Germany, to coordinate a European Union grant for Phase II trials of SQ109 in adult pulmonary tuberculosis at seven sites in Africa

Labopharm Inc., of Laval, Quebec, said its twice-daily tramadol-acetaminophen received a positive opinion under the European Union Decentralized Procedure in eight countries

AstraZeneca plc, of London, and Pozen Inc., of Chapel Hill, N.C., said that Vimovo (naproxen/ esomeprazole magnesium) 500/20 mg modified-release tablets cleared an important regulatory milestone by receiving positive agreement for approval in 23 countries across the European Union

If approved, Tibotec will commercialize TMC278 in the European Union

If approved, Tibotec will commercialize TMC278 in the European Union

Inc., of Whitehouse Station, N.J., and Cardiome Pharma Corp., of Vancouver, British Columbia, said intravenous formulation of Brinavess (vernakalant) has been granted marketing approval in the European Union, Iceland and Norway for the rapid conversion of recent onset atrial fibrillation (AF) to sinus rhythm for nonsurgery adult patients with AF of seven days or less and for postcardiac surgery patients with AF of three days or less

and European Union

Once that plan is approved, CTI will submit a marketing authorization application for pixantrone in the European Union later this year

Optimer Pharmaceuticals Inc., of San Diego, submitted a marketing authorization application for fidaxomicin, a macrocycle, which inhibits the bacterial enzyme RNA polymerase, to the European Medicines Agency under the European Union's centralized procedure as a treatment for Clostridium difficile infection

It will allow patients with Gaucher's disease in France to receive treatment with taliglucerase alfa before marketing authorization for the product is granted in the European Union